Icahn, Eastbourne Put Pressure on Amylin Pharmaceuticals, Inc. Board
BOSTON, Feb. 2 (Reuters) - A battle looks set to break out
for control of Amylin Pharmaceuticals Inc (AMLN.O), maker of the
diabetes drug Byetta, as two big investors move to shake up the
board.